| ADSCs | adipose derived stem cells |
| ALS | amyotrophic lateral sclerosis |
| AT | adipose tissue |
| b-FGF | basic Fibroblast Growth Factor |
| BM | bone marrow |
| CCL-2 | Chemokine C-C Motif Ligand-2 |
| cGMP | current good manufacturing practices |
| ECM | extracellular matrix |
| EGF | Endothelial Growth Factor |
| G-CSF | Granulocyte-Colony Stimulating Factor |
| GDF-11, -15 | Growth Differentiation Factor-11, -15 |
| GM-CSF | Granulocyte Monocyte-Colony Stimulating Factor |
| GVHD | graft versus host disease |
| HSCs | hematopoietic stem cells |
| IFATS | International Federation of Adipose Therapeutics |
| IGF | Insulin Growth Factor |
| IL-1, -6, -10 | Interleukin-1, -6, -10 |
| ISCT | International Society for Cellular Therapy |
| KGF | Keratinocyte Growth Factor |
| MS | multiple sclerosis |
| MSCs | mesenchymal stem/stromal cells |
| NGF | Nerve Growth Factor |
| PDGF | Platelet Derived Growth Factor |
| PEDF | Pigment Epithelium Derived Factor |
| SLE | systemic lupus erythematosus |
| SS | systemic sclerosis |
| SVF | Stromal vascular fraction |
| TGF-β | Tumor growth factor-β |
| TLR2, 4 | Toll-like Receptor 2, 4 |
| TNF-α | Tumor necrosis factor-α |
| UC | umbilical cord |
| UCB | umbilical cord blood |
| VEGF | Vascular Endothelial Growth Factor |